Holland v. Smith & Nephew Richards, Inc.

100 F. Supp. 2d 53, 1999 U.S. Dist. LEXIS 22027, 1999 WL 1133319
CourtDistrict Court, D. Massachusetts
DecidedSeptember 28, 1999
DocketCiv.A.96-12396-GAO
StatusPublished
Cited by5 cases

This text of 100 F. Supp. 2d 53 (Holland v. Smith & Nephew Richards, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Holland v. Smith & Nephew Richards, Inc., 100 F. Supp. 2d 53, 1999 U.S. Dist. LEXIS 22027, 1999 WL 1133319 (D. Mass. 1999).

Opinion

MEMORANDUM AND ORDER

O’TOOLE, District Judge.

The plaintiff Thomas Holland brought this action against the defendant Smith & *54 Nephew Richards, Inc. (“Smith & Nephew”), seeking damages for injuries he attributes to the use of a medical device manufactured and sold by Smith & Nephew. Although, as will be seen, the plaintiffs overall theory involves the role of the federal Food and Drug Administration (“FDA”) in regulating medical devices, the complaint asserts only state law claims. 1

This case is one of more than two thousand separate actions filed in various districts claiming that defective “pedicle screw fixation devices” caused plaintiffs to suffer physical injuries. Pursuant to 28 U.S.C. § 1407, the Judicial Panel on Mul-ti-District Litigation transferred the cases to the United States District Court for the Eastern District of Pennsylvania for consolidated pretrial proceedings. MDL Docket No. 1014. After this case was remanded for final disposition, the defendant moved for summary judgment as to all of the plaintiffs claims.

Facts 2

Thomas Holland injured his back in a car accident in December, 1989. After non-surgical treatment failed to yield satisfactory results, in August, 1992, Holland’s treating physician referred Holland to Dr. Warren Courville, an orthopedic surgeon. See Coo Aff., Dkt. No. 14, Ex. C. (Massand Dep.) At 33:22-24, 34:1-18; Ex. B (medical records). On October 22, 1992, Dr. Courville performed spinal fusion surgery on Holland using internal fixation hardware manufactured and marketed by Smith & Nephew as the “Simmons Plating System” (apparently named after the doctor who designed it).

Briefly stated, the Simmons Plating System employs steel plates to hold the spine rigid so that the intended bone fusion can succeed. The plates are fixed in place by means of screws. In Holland’s surgery, Dr. Courville inserted the screws into the lumbar pedicles, which are bony extensions on either side of the spinal vertebrae.

The surgery did not accomplish the intended relief of Holland’s symptoms and in some respects made things worse. In early 1994, surgery was performed to remove the hardware. The parties do not dispute that two screws inserted in the left pedicle invaded the spinal canal and impinged on the nerve roots. For the consequent injury and suffering Holland seeks to hold Smith & Nephew responsible.

Under the Medical Device Amendments of 1976 (“MDA”), 21 U.S.C. §§ 360c-36.0k, to the Food, Drug, and Cosmetic Act of 1938 (“FDCA”), 21 U.S.C. §§ 301 et seq., the FDA has the authority and responsibility to regulate the marketing and labeling of medical devices. The regulatory regime is complex, but it is sufficient for present purposes to note that a device like the Simmons Plating System cannot be marketed unless it has received thorough evaluation and “premarket approval” by the FDA, subject to limited exceptions. See In re Orthopedic Bone Screw Prods., Liab. Litig., 159 F.3d 817, 818-20 (3rd Cir.1998) (outlining regulatory provisions). One of the exceptions is that the device is “sub *55 stantially equivalent” to a device that was in use as of the enactment of the MDA. Id. at 819.

In October 1991, the FDA notified Smith & Nephew that it had cleared the Simmons Plating System to be marketed on the basis of the agency’s determination that “the device system is substantially equivalent to device systems marketed in interstate commerce prior to May 28, 1976.” Coo Aff., Ex. G. The FDA added:

This decision is based on your device system being found equivalent only to similar device systems labeled and intended to be fixed/attached to the spine by screw fixation/attachment to the an-terolateral intervertebral bodies only.
This device system, if intended for use in pedicle screw fixation/attachment, would be found not substantially equivalent and would be a class III devico under Section 513(f) of the Act. Class III devices are required to have an approved premarket approval (PMA) application prior to marketing.

Id. (emphasis in original).

With FDA clearance, Smith & Nephew began marketing the Simmons Plating System. Consistent with the limitation imposed by the FDA, the brochure provided with the system contained the following statement at two places, once in capital letters: “CAUTION: THE SIMMONS PLATING SYSTEM IS INTENDED FOR SCREW FIXATION/ATTACHMENT TO THE ANTEROLATERAL INTERVERTEBRAL BODIES ONLY.” Coo Aff., Ex F at SNR0034783, SNR0034796.

Although the Simmons Plating System was not cleared by the FDA for use as a device to be attached to the pedicles, surgeons began using it in that fashion anyway. Use of a device (or a drug) in a way not approved by the FDA — called “off-label use” — is a widespread practice in the medical community. See In re Orthopedic Bone Screw Litig., 159 F.3d at 830-31 & n. 1 (Cowen, J., dissenting). The FDA has recognized that it cannot regulate the medical judgments that lead to off-label use. In a paper issued by the FDA December 21, 1993, entitled “Update on Pedi-cle Screws,” the agency noted:

In practice, surgeons often use orthopedic screws which FDA has cleared for other purposes, such as repairing long bones in the arms and legs, as pedicle screws. Such use of medical devices for non-approved purposes has traditionally been regulated by the hospitals in which physicians practice and by their state medical boards, not by FDA.

Bierhans Aff., Ex. 40 at 2.

What the FDA does regulate is the promotion and marketing of such devices by manufacturers. In the same “Update,” the FDA further noted:

To encourage surgeons to use orthopedic screws in the pedicles of the spine, some manufacturers have been promoting this practice through professional advertising and training courses. This type of promotion is illegal.

Id. The plaintiff offers evidence that Smith & Nephew participated in, even sponsored, “continuing medical education” seminars that promoted the pedicle fixation use of the Simmons Plating System, contrary to the. limitation imposed by the FDA. The plaintiffs surgeon, Dr. Courville, attended some of these seminars and there received instruction from other orthopedic surgeons in the use of the Simmons Plating System, and other similar devices, as a method for internal fixation using pedicle screws.

In October, 1992, when he performed Holland’s surgery, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Fertik v. Stevenson
186 F. Supp. 3d 98 (D. Massachusetts, 2016)
Shannon v. Fusco
89 A.3d 1156 (Court of Appeals of Maryland, 2014)
Blazoski v. Cook
787 A.2d 910 (New Jersey Superior Court App Division, 2002)
Southard v. Temple University Hospital
781 A.2d 101 (Supreme Court of Pennsylvania, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
100 F. Supp. 2d 53, 1999 U.S. Dist. LEXIS 22027, 1999 WL 1133319, Counsel Stack Legal Research, https://law.counselstack.com/opinion/holland-v-smith-nephew-richards-inc-mad-1999.